Sexual Function and Quality of Life in a National Cohort of Survivors of Bilateral Testicular Cancer

Publikation: Bidrag til tidsskrift/Konferencebidrag i tidsskrift /Bidrag til avisTidsskriftartikelForskningpeer review

Standard

Sexual Function and Quality of Life in a National Cohort of Survivors of Bilateral Testicular Cancer. / Bandak, Mikkel; Lauritsen, Jakob; Johansen, Christoffer; Kreiberg, Michael; Skøtt, Julie Wang; Agerbaek, Mads; Holm, Niels V.; Daugaard, Gedske.

I: European Urology Focus, Bind 6, Nr. 4, 07.2020, s. 711-719.

Publikation: Bidrag til tidsskrift/Konferencebidrag i tidsskrift /Bidrag til avisTidsskriftartikelForskningpeer review

Harvard

Bandak, M, Lauritsen, J, Johansen, C, Kreiberg, M, Skøtt, JW, Agerbaek, M, Holm, NV & Daugaard, G 2020, 'Sexual Function and Quality of Life in a National Cohort of Survivors of Bilateral Testicular Cancer', European Urology Focus, bind 6, nr. 4, s. 711-719. https://doi.org/10.1016/j.euf.2018.11.007

APA

Bandak, M., Lauritsen, J., Johansen, C., Kreiberg, M., Skøtt, J. W., Agerbaek, M., Holm, N. V., & Daugaard, G. (2020). Sexual Function and Quality of Life in a National Cohort of Survivors of Bilateral Testicular Cancer. European Urology Focus, 6(4), 711-719. https://doi.org/10.1016/j.euf.2018.11.007

CBE

Bandak M, Lauritsen J, Johansen C, Kreiberg M, Skøtt JW, Agerbaek M, Holm NV, Daugaard G. 2020. Sexual Function and Quality of Life in a National Cohort of Survivors of Bilateral Testicular Cancer. European Urology Focus. 6(4):711-719. https://doi.org/10.1016/j.euf.2018.11.007

MLA

Vancouver

Bandak M, Lauritsen J, Johansen C, Kreiberg M, Skøtt JW, Agerbaek M o.a. Sexual Function and Quality of Life in a National Cohort of Survivors of Bilateral Testicular Cancer. European Urology Focus. 2020 jul;6(4):711-719. https://doi.org/10.1016/j.euf.2018.11.007

Author

Bandak, Mikkel ; Lauritsen, Jakob ; Johansen, Christoffer ; Kreiberg, Michael ; Skøtt, Julie Wang ; Agerbaek, Mads ; Holm, Niels V. ; Daugaard, Gedske. / Sexual Function and Quality of Life in a National Cohort of Survivors of Bilateral Testicular Cancer. I: European Urology Focus. 2020 ; Bind 6, Nr. 4. s. 711-719.

Bibtex

@article{b32ea3fafc114a4785263380798c9af8,
title = "Sexual Function and Quality of Life in a National Cohort of Survivors of Bilateral Testicular Cancer",
abstract = "Background: Sexual function and quality of life remain unexplored among long-term survivors of bilateral testicular cancer (TC). Objective: To investigate sexual function, fatigue, anxiety, and depression among long-term survivors of bilateral TC (unilateral TC with contralateral germ cell neoplasia in situ [TC + GCNIS] or bilateral TC [BTC]). Design, setting, and participants: This was a cross-sectional study of 2479 long-term TC survivors, of whom 126 were treated with contralateral radiotherapy for GCNIS, 93 were treated with bilateral orchiectomy for BTC, and 2260 had unilateral TC (reference group). Outcome measurements and statistical analysis: Outcomes were assessed using validated questionnaires at a median time since diagnosis of 17 yr (interquartile range 12–23). Results for survivors of TC + GCNIS and of BTC were compared with those for the reference group. Adjustment was made for age and treatment for disseminated disease. Results and limitations: The age-adjusted risk of anxiety was significantly higher among BTC survivors (odds ratio 1.7, 95% confidence interval [CI] 1.1–2.8; p = 0.002) than in the reference group. Apart from a higher risk of reduced motivation among survivors of TC + GCNIS (β = 0.067, 95% CI 0.0013–0.13; p = 0.046) there were no significant differences between the groups. Limitations include the low number of cases with symptoms of depression. Conclusions: Survivors of BTC had a higher risk of anxiety but did not experience impairment of other aspects of quality of life when compared to survivors of unilateral TC. These results are of importance for evidence-based information on late effects for bilateral TC patients. Patient summary: We evaluated quality of life and sexual function among long-term survivors of bilateral testicular cancer. Reassuringly, we did not find impaired quality of life apart from a higher risk of anxiety when comparing survivors of bilateral testicular cancer with survivors of unilateral testicular cancer. Long-term survivors of bilateral testicular cancer had a higher risk of anxiety but not of sexual dysfunction when compared to long-term survivors of unilateral testicular cancer.",
keywords = "Bilateral orchiectomy, Germ cell neoplasia in situ, Late effects, Sexual dysfunction, Testicular cancer, Testosterone deficiency",
author = "Mikkel Bandak and Jakob Lauritsen and Christoffer Johansen and Michael Kreiberg and Sk{\o}tt, {Julie Wang} and Mads Agerbaek and Holm, {Niels V.} and Gedske Daugaard",
year = "2020",
month = jul,
doi = "10.1016/j.euf.2018.11.007",
language = "English",
volume = "6",
pages = "711--719",
journal = "European Urology Focus",
issn = "2405-4569",
publisher = "Elsevier BV",
number = "4",

}

RIS

TY - JOUR

T1 - Sexual Function and Quality of Life in a National Cohort of Survivors of Bilateral Testicular Cancer

AU - Bandak, Mikkel

AU - Lauritsen, Jakob

AU - Johansen, Christoffer

AU - Kreiberg, Michael

AU - Skøtt, Julie Wang

AU - Agerbaek, Mads

AU - Holm, Niels V.

AU - Daugaard, Gedske

PY - 2020/7

Y1 - 2020/7

N2 - Background: Sexual function and quality of life remain unexplored among long-term survivors of bilateral testicular cancer (TC). Objective: To investigate sexual function, fatigue, anxiety, and depression among long-term survivors of bilateral TC (unilateral TC with contralateral germ cell neoplasia in situ [TC + GCNIS] or bilateral TC [BTC]). Design, setting, and participants: This was a cross-sectional study of 2479 long-term TC survivors, of whom 126 were treated with contralateral radiotherapy for GCNIS, 93 were treated with bilateral orchiectomy for BTC, and 2260 had unilateral TC (reference group). Outcome measurements and statistical analysis: Outcomes were assessed using validated questionnaires at a median time since diagnosis of 17 yr (interquartile range 12–23). Results for survivors of TC + GCNIS and of BTC were compared with those for the reference group. Adjustment was made for age and treatment for disseminated disease. Results and limitations: The age-adjusted risk of anxiety was significantly higher among BTC survivors (odds ratio 1.7, 95% confidence interval [CI] 1.1–2.8; p = 0.002) than in the reference group. Apart from a higher risk of reduced motivation among survivors of TC + GCNIS (β = 0.067, 95% CI 0.0013–0.13; p = 0.046) there were no significant differences between the groups. Limitations include the low number of cases with symptoms of depression. Conclusions: Survivors of BTC had a higher risk of anxiety but did not experience impairment of other aspects of quality of life when compared to survivors of unilateral TC. These results are of importance for evidence-based information on late effects for bilateral TC patients. Patient summary: We evaluated quality of life and sexual function among long-term survivors of bilateral testicular cancer. Reassuringly, we did not find impaired quality of life apart from a higher risk of anxiety when comparing survivors of bilateral testicular cancer with survivors of unilateral testicular cancer. Long-term survivors of bilateral testicular cancer had a higher risk of anxiety but not of sexual dysfunction when compared to long-term survivors of unilateral testicular cancer.

AB - Background: Sexual function and quality of life remain unexplored among long-term survivors of bilateral testicular cancer (TC). Objective: To investigate sexual function, fatigue, anxiety, and depression among long-term survivors of bilateral TC (unilateral TC with contralateral germ cell neoplasia in situ [TC + GCNIS] or bilateral TC [BTC]). Design, setting, and participants: This was a cross-sectional study of 2479 long-term TC survivors, of whom 126 were treated with contralateral radiotherapy for GCNIS, 93 were treated with bilateral orchiectomy for BTC, and 2260 had unilateral TC (reference group). Outcome measurements and statistical analysis: Outcomes were assessed using validated questionnaires at a median time since diagnosis of 17 yr (interquartile range 12–23). Results for survivors of TC + GCNIS and of BTC were compared with those for the reference group. Adjustment was made for age and treatment for disseminated disease. Results and limitations: The age-adjusted risk of anxiety was significantly higher among BTC survivors (odds ratio 1.7, 95% confidence interval [CI] 1.1–2.8; p = 0.002) than in the reference group. Apart from a higher risk of reduced motivation among survivors of TC + GCNIS (β = 0.067, 95% CI 0.0013–0.13; p = 0.046) there were no significant differences between the groups. Limitations include the low number of cases with symptoms of depression. Conclusions: Survivors of BTC had a higher risk of anxiety but did not experience impairment of other aspects of quality of life when compared to survivors of unilateral TC. These results are of importance for evidence-based information on late effects for bilateral TC patients. Patient summary: We evaluated quality of life and sexual function among long-term survivors of bilateral testicular cancer. Reassuringly, we did not find impaired quality of life apart from a higher risk of anxiety when comparing survivors of bilateral testicular cancer with survivors of unilateral testicular cancer. Long-term survivors of bilateral testicular cancer had a higher risk of anxiety but not of sexual dysfunction when compared to long-term survivors of unilateral testicular cancer.

KW - Bilateral orchiectomy

KW - Germ cell neoplasia in situ

KW - Late effects

KW - Sexual dysfunction

KW - Testicular cancer

KW - Testosterone deficiency

UR - http://www.scopus.com/inward/record.url?scp=85056987853&partnerID=8YFLogxK

U2 - 10.1016/j.euf.2018.11.007

DO - 10.1016/j.euf.2018.11.007

M3 - Journal article

C2 - 30482585

AN - SCOPUS:85056987853

VL - 6

SP - 711

EP - 719

JO - European Urology Focus

JF - European Urology Focus

SN - 2405-4569

IS - 4

ER -